Mortality results from a randomized prostate-cancer screening trial.

L Andriole, Gerald; David Crawford, E; L Grubb, Robert; S Buys, Saundra; Chia, David; R Church, Timothy; N Fouad, Mona; P Gelmann, Edward; A Kvale, Paul; J Reding, Douglas; L Weissfeld, Joel; A Yokochi, Lance; O'Brien, Barbara; D Clapp, Jonathan; M Rathmell, Joshua; L Riley, Thomas; B Hayes, Richard; S Kramer, Barnett; Izmirlian, Grant; B Miller, Anthony; F Pinsky, Paul; C Prorok, Philip; K Gohagan, John; D Berg, Christine; Project Team, PLCO

doi:10.1056/NEJMoa0810696

Public

Mortality results from a randomized prostate-cancer screening trial.

Shared by NobleBlocks on Mar 26, 2009 • 12:00 AM UTC

Authors:

Gerald L Andriole

E David Crawford

Robert L Grubb

Abstract

BACKGROUND: The effect of screening with prostate-specific-antigen (PSA) testing and digital rectal examination on the rate of death from prostate cancer is unknown. This is the first report from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial on prostate-cancer mortality. ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!